INS and obesity due to melanocortin 4 receptor deficiency: The existence of the “metabolically healthy obesity (MHO)” phenotype further complicates interpretation, as some obese individuals may maintain preserved insulin sensitivity and relatively low systemic inflammation [29, 37, 38], which our analysis could not disentangle.